Teleanu, Maria-Veronica Dr. med.Universität HeidelbergHeidelberg
Refine publication list
Year of publication
Type of Publication
Language
Co-author (Univ. of Heidelberg)
- Mock, Andreas (5)
- Brors, Benedikt (5)
- Schlenk, Richard Friedrich (5)
- Hutter, Barbara (5)
- Penzel, Roland (4)
- Allgäuer, Michael (4)
- Lipka, Daniel (4)
- Schirmacher, Peter (3)
- Renner, Marcus (3)
- Hohenberger, Peter (3)
- Neumann, Olaf (3)
- Endris, Volker (3)
- Gieldon, Laura (3)
- Kalle, Christof von (2)
- Hüllein, Jennifer (2)
- Uhrig, Sebastian (2)
- Andresen, Carolin (2)
- Laßmann, Andreas (2)
- Müller-Tidow, Carsten (1)
- Kirchner, Martina (1)
- Köhler, Bruno Christian (1)
- Eils, Roland (1)
- Mechtersheimer, Gunhild (1)
- Goeppert, Benjamin (1)
- Paramasivam, Nagarajan (1)
- Jäger, Dirk (1)
- Fröhlich, Martina (1)
- Steindorf, Karen (1)
- Egerer, Gerlinde (1)
- Brandt, Regine (1)
- Benner, Axel (1)
- Dikow, Nicola (1)
- Şeker-Cin, Huriye (1)
- (further entries exist...)
Co-author (external)
Publications in heiBIB 
- Remde, Hanna: Outcome of immunotherapy in adrenocortical carcinoma : a retrospective cohort study / Hanna Remde, Laura Schmidt-Pennington, Miriam Reuter, Laura-Sophie Landwehr, Marie Jensen, Harald La… , June 2023. - 9 S. : Illustrationen
In: European journal of endocrinology, ISSN 1479-683X. 188(2023), 6 vom: Juni, Seite 485-493
DOI: 10.1093/ejendo/lvad054
- Horak, Peter: Assigning evidence to actionability : an introduction to variant interpretation in precision cancer medicine / Peter Horak, Jonas Leichsenring, Hannah Goldschmid, Simon Kreutzfeldt, Daniel Kazdal, Veronica Telea… , June 2022. - 11 S.
In: Genes, chromosomes & cancer, ISSN 1098-2264. 61(2022), 6, 6, Seite 303-313
DOI: 10.1002/gcc.22987
- Jahn, Arne: Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers / A. Jahn, A. Rump, T.J. Widmann, C. Heining, P. Horak, B. Hutter, N. Paramasivam, S. Uhrig, L. Gieldo… , 18 August 2022. - 14 S.
In: Annals of oncology, ISSN 1569-8041. 33(2022), 11, Seite 1186-1199
DOI: 10.1016/j.annonc.2022.07.008
- Heilig, Christoph E.: Gene expression-based prediction of pazopanib efficacy in sarcoma / Christoph E. Heilig, Andreas Laßmann, Sadaf S. Mughal, Andreas Mock, Sebastian Pirmann, Veronica Tel… , 25 June 2022. - 12 S.
In: European journal of cancer, ISSN 1879-0852. 172(2022), Seite 107-118
DOI: 10.1016/j.ejca.2022.05.025
- Möhrmann, Lino: Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity / Lino Möhrmann, Maximilian Werner, Małgorzata Oleś, Andreas Mock, Sebastian Uhrig, Arne Jahn, Simon K… , 02 August 2022. - 15 S.
In: Nature Communications, ISSN 2041-1723. 13(2022), Artikel-ID 4485, Seite 1-15
DOI: 10.1038/s41467-022-31866-4
- Hübschmann, Daniel: Analysis of mutational signatures with yet another package for signature analysis / Daniel Hübschmann, Lea Jopp-Saile, Carolin Andresen, Stephen Krämer, Zuguang Gu, Christoph E. Heilig… , May 2021. - 18 S.
In: Genes, chromosomes & cancer, ISSN 1098-2264. 60(2021), 5, special issue vom: Mai, Seite 314-331
DOI: 10.1002/gcc.22918
- Heilig, Christoph E.: Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial / C.E. Heilig, P. Horak, S. Kreutzfeldt, V. Teleanu, A. Mock, M. Renner, I.A. Bhatti, B. Hutter, J. Hü… , 20 November 2021. - 5 S.
In: ESMO open, ISSN 2059-7029. 6(2021), 6, Artikel-ID 100310, Seite 1-5
DOI: 10.1016/j.esmoop.2021.100310
- Jaramillo Segura, Sonia: Ruxolitinib is effective in the treatment of a patient with refractory T-ALL / Sonia Jaramillo, Hannah Hennemann, Peter Horak, Veronica Teleanu, Christoph E. Heilig, Barbara Hutte… , 2021. - 4 S.
In: eJHaem, ISSN 2688-6146. 2(2021), 1, Seite 139-142
DOI: 10.1002/jha2.143
- Horak, Peter: Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers / Peter Horak, Christoph Heining, Simon Kreutzfeldt, Barbara Hutter, Andreas Mock, Jennifer Hullein, M… , June 10, 2021. - 16 S.
In: Cancer discovery, ISSN 2159-8290. 11(2021), 11, Seite 2780-2795
DOI: 10.1158/2159-8290.CD-21-0126
